Cyclopharm Limited reported earnings results for the half year ended June 30, 2023. For the half year, the company reported sales was AUD 15.72 million compared to AUD 11.41 million a year ago. Revenue was AUD 16.49 million compared to AUD 11.43 million a year ago.

Net loss was AUD 2.9 million compared to AUD 2.56 million a year ago. Basic loss per share from continuing operations was AUD 0.0315 compared to AUD 0.0278 a year ago. Diluted loss per share from continuing operations was AUD 0.0315 compared to AUD 0.0278 a year ago.